PMC:7445716 / 14098-15388
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T44 | 871-874 | Body_part | denotes | CSF | http://purl.org/sig/ont/fma/fma20935 |
T45 | 1015-1018 | Body_part | denotes | CSF | http://purl.org/sig/ont/fma/fma20935 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T158 | 76-79 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T159 | 206-228 | Disease | denotes | Miller Fisher syndrome | http://purl.obolibrary.org/obo/MONDO_0005851 |
T160 | 230-233 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T161 | 234-237 | Disease | denotes | MFS | http://purl.obolibrary.org/obo/MONDO_0007947|http://purl.obolibrary.org/obo/MONDO_0019202|http://purl.obolibrary.org/obo/MONDO_0005851 |
T164 | 266-278 | Disease | denotes | polyneuritis | http://purl.obolibrary.org/obo/MONDO_0021718 |
T165 | 301-313 | Disease | denotes | facial palsy | http://purl.obolibrary.org/obo/MONDO_0001835|http://purl.obolibrary.org/obo/MONDO_0005665 |
T167 | 308-313 | Disease | denotes | palsy | http://purl.obolibrary.org/obo/MONDO_0006496 |
T168 | 616-620 | Disease | denotes | AIDP | http://purl.obolibrary.org/obo/MONDO_0020347 |
T169 | 647-652 | Disease | denotes | AMSAN | http://purl.obolibrary.org/obo/MONDO_0020348 |
T170 | 674-678 | Disease | denotes | AMAN | http://purl.obolibrary.org/obo/MONDO_0020349 |
T171 | 832-835 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T100 | 151-152 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T101 | 622-624 | http://purl.obolibrary.org/obo/CLO_0053799 | denotes | 45 |
T102 | 698-699 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T103 | 762-764 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
T104 | 980-982 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
305 | 126-134 | Species | denotes | patient | Tax:9606 |
306 | 409-417 | Species | denotes | patient | Tax:9606 |
307 | 764-772 | Species | denotes | patient | Tax:9606 |
308 | 926-934 | Species | denotes | patient | Tax:9606 |
309 | 1082-1090 | Species | denotes | patient | Tax:9606 |
310 | 646-651 | Chemical | denotes | AMSA | |
311 | 233-236 | Disease | denotes | /MF | MESH:D008382 |
312 | 265-287 | Disease | denotes | polyneuritis craniali | MESH:D009443 |
313 | 290-312 | Disease | denotes | bilateral facial pals | MESH:D005158 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T105 | 0-79 | Sentence | denotes | Distribution of clinical and electrophysiological variants and diagnosis of GBS |
T106 | 80-433 | Sentence | denotes | From the clinical point of view, most examined patients presented with a classic sensorimotor variant (70.0%, 51/73), whereas Miller Fisher syndrome, GBS/MFS overlap variants (including polyneuritis cranialis), bilateral facial palsy with paresthesia, pure motor, and paraparetic were described in seven, two, five, four, and one patients, respectively. |
T107 | 434-528 | Sentence | denotes | In three cases, no clinical variant could be established using the reported details (Table 1). |
T108 | 529-688 | Sentence | denotes | In the examined population, 81.8% subjects fulfilled electrophysiological criteria for AIDP (45/55), 12.7% (7/55) for AMSAN, and 5.4% (3/55) for AMAN subtypes. |
T109 | 689-814 | Sentence | denotes | Finally, a specific electrophysiological subtype was not attributable in 18 patients due to the lack of detailed information. |
T110 | 815-1092 | Sentence | denotes | The diagnosis of GBS was established based on clinical, CSF, and electrophysiological findings in 44/73 (60.3%) patients, clinical, and electrophysiological data in 18/73 (24.7%) cases, clinical, and CSF data in 8/73 (11.0%), and only clinical findings in 3/73 (4.1%) patients. |
T111 | 1093-1192 | Sentence | denotes | Indeed, the highest level of diagnostic certainty (level one) was confirmed in 44/73 cases (60.3%). |
T112 | 1193-1290 | Sentence | denotes | Level two and three were obtained in 24/73 cases (32.9%) and 5/73 (6.8%), respectively (Table 1). |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T57 | 266-278 | Phenotype | denotes | polyneuritis | http://purl.obolibrary.org/obo/HP_0031003 |
T58 | 291-313 | Phenotype | denotes | bilateral facial palsy | http://purl.obolibrary.org/obo/HP_0430025 |
T59 | 319-330 | Phenotype | denotes | paresthesia | http://purl.obolibrary.org/obo/HP_0003401 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T128 | 161-173 | UBERON:0025534 | denotes | sensorimotor |
T129 | 301-307 | UBERON:0001456 | denotes | facial |